Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are included in the 2010 ACR/EULAR criteria because of their high sensitivity and specificity in RA patients [1]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.